COST

952.78

+1.41%↑

KO

68.85

+1.4%↑

PM

162.98

-0.66%↓

PEP

139.33

+1%↑

KDP.US

33.34

+2.18%↑

COST

952.78

+1.41%↑

KO

68.85

+1.4%↑

PM

162.98

-0.66%↓

PEP

139.33

+1%↑

KDP.US

33.34

+2.18%↑

COST

952.78

+1.41%↑

KO

68.85

+1.4%↑

PM

162.98

-0.66%↓

PEP

139.33

+1%↑

KDP.US

33.34

+2.18%↑

COST

952.78

+1.41%↑

KO

68.85

+1.4%↑

PM

162.98

-0.66%↓

PEP

139.33

+1%↑

KDP.US

33.34

+2.18%↑

COST

952.78

+1.41%↑

KO

68.85

+1.4%↑

PM

162.98

-0.66%↓

PEP

139.33

+1%↑

KDP.US

33.34

+2.18%↑

Search

Lifecore Biomedical Inc

Slēgts

SektorsPatēriņa aizsardzības

6.98 0.29

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

6.77

Max

7.02

Galvenie mērījumi

By Trading Economics

Ienākumi

-8.2M

-15M

Pārdošana

2.6M

35M

P/E

Sektora vidējais

201.137

27.757

EPS

-0.253

Peļņas marža

-42.012

Darbinieki

524

EBITDA

-5.5M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+28.57% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 7. aug.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

89M

263M

Iepriekšējā atvēršanas cena

6.69

Iepriekšējā slēgšanas cena

6.98

Ziņu noskaņojums

By Acuity

100%

0%

146 / 150 Rangs Consumer defensive

Lifecore Biomedical Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 1. aug. 17:41 UTC

Peļņas
Galvenie tirgus virzītāji

Colgate Plans More Price Increases to Offset Slower Sales, Higher Costs -- Update

2025. g. 1. aug. 17:40 UTC

Peļņas
Galvenie tirgus virzītāji

Colgate Plans More Price Increases to Offset Slower Sales, Higher Costs -- Update

2025. g. 1. aug. 22:31 UTC

Peļņas

MicroStrategy Stock Drops 9%. New Equity Guidelines Could Be the Reason. -- Barrons.com

2025. g. 1. aug. 20:50 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2025. g. 1. aug. 20:28 UTC

Iegādes, apvienošanās, pārņemšana

EOG Resources Completes $5.6B Purchase of Encino Acquisition Partners

2025. g. 1. aug. 20:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2025. g. 1. aug. 20:08 UTC

Tirgus saruna

U.S. Stocks Tumble as U.S. Jobs Market Weakens, New Tariffs Hit -- Market Talk

2025. g. 1. aug. 19:54 UTC

Tirgus saruna

Mexico Manufacturing Indexes Mixed in July -- Market Talk

2025. g. 1. aug. 19:54 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 1. aug. 19:42 UTC

Tirgus saruna

Treasury Yields Start Month With Jobs-Driven Decline -- Market Talk

2025. g. 1. aug. 19:40 UTC

Tirgus saruna

Global Energy Roundup: Market Talk

2025. g. 1. aug. 19:40 UTC

Tirgus saruna

U.S. Natural Gas Futures Hold Above Key Support -- Market Talk

2025. g. 1. aug. 19:19 UTC

Tirgus saruna

Livestock Brings Positive Momentum Into August -- Market Talk

2025. g. 1. aug. 19:13 UTC

Tirgus saruna

Crude Falls on Soft U.S. Jobs Data, OPEC+ Output Expectations -- Market Talk

2025. g. 1. aug. 19:07 UTC

Iegādes, apvienošanās, pārņemšana

Danone to Explore Buying Lifeway Foods. The Third Time Could Be Different. -- Barrons.com

2025. g. 1. aug. 18:38 UTC

Tirgus saruna

Grains Shrug Off Lower Dollar -- Market Talk

2025. g. 1. aug. 18:38 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 1. aug. 17:53 UTC

Iegādes, apvienošanās, pārņemšana

Correction to M&A Is Back. These Stocks Could Be Targets. -- Barrons.com

2025. g. 1. aug. 17:52 UTC

Tirgus saruna

Gold Finishes Higher Amid Weak July Hiring and Tariffs -- Market Talk

2025. g. 1. aug. 17:38 UTC

Tirgus saruna

U.S. Oil Rig Count Down By 5 to 410 -- Market Talk

2025. g. 1. aug. 17:06 UTC

Peļņas

Earnings Season Is Going Really Well. Don't Overthink It. -- Barrons.com

2025. g. 1. aug. 16:55 UTC

Peļņas

Big Takeaways From Big Tech Earnings -- Barrons.com

2025. g. 1. aug. 16:46 UTC

Peļņas

Apple's Earnings Were a Pleasant Surprise. There's More Work Ahead. -- Barrons.com

2025. g. 1. aug. 16:36 UTC

Tirgus saruna

Oil Extends Losses on Tariffs, Weak U.S. Payrolls -- Market Talk

2025. g. 1. aug. 16:20 UTC

Tirgus saruna
Peļņas

Energy & Utilities Roundup: Market Talk

2025. g. 1. aug. 16:20 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 1. aug. 16:03 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

Exxon Stock Slips After Earnings. The CEO May Have Spooked Investors. -- Barrons.com

2025. g. 1. aug. 16:00 UTC

Iegādes, apvienošanās, pārņemšana

Marsh McLennan Agency Acquires Olympic Insurance Agency >MMC

2025. g. 1. aug. 15:29 UTC

Tirgus saruna

Soybeans Higher After Weeklong Losing Streak -- Market Talk

2025. g. 1. aug. 15:21 UTC

Tirgus saruna

AWS Can Still Accelerate Despite Near-Term Concerns -- Market Talk

Salīdzinājums

Cenas izmaiņa

Lifecore Biomedical Inc Prognoze

Cenas mērķis

By TipRanks

28.57% augšup

Prognoze 12 mēnešiem

Vidējais 9 USD  28.57%

Augstākais 9 USD

Zemākais 9 USD

Pamatojoties uz 2 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Lifecore Biomedical Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

2 ratings

2

Pirkt

0

Turēt

0

Pārdot

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Lifecore Biomedical Inc

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.